CRP and chronic obstructive pulmonary disease: As compared to patients without COVID-19, patients with COVID-19 had a higher prevalence of hypertension (50% vs 36%), diabetes (46% vs 33%), and chronic obstructive pulmonary disease (COPD) (21% vs 14%), as well as higher CRP values at admission, higher initial temperature, lower DBP, lower SpO2 and more frequent prescription of low molecular weight heparin (LMWH)/non-vitamin-k oral anticoagulant (NOAC)/warfarin(84% vs 57%) and antibiotics(50% vs 41%) (Supplemental Table S2).